Arnoldas Doviltis, general manager of Ferring Austria, a research-driven Swiss biopharmaceutical company, elaborates on the autonomous nature of local Ferring affiliates and how this allows a tailored approach to conduct Austrian operations. Furthermore, he provides an insight into the peculiarities of market access within Austria compared to other European nations as well as how the exciting probiotic range is seen as a game changer for Ferring within the Austrian market.
Could you please introduce to our international readers the current operations of Ferring Austria and how your experience has prepared you for such a task?
"Globally fertility is the largest business for Ferring, however, Austria has been the most successful among all affiliates worldwide in terms of obstetrics."
